Particle.news

Download on the App Store

Bavaria Reports Sharp Rise in Lyme-Borreliose Cases in 2025

No vaccine exists, so early detection remains the key defense.

Overview

  • The Bavarian health ministry reports 4,156 Lyme-Borreliose cases so far this year, up from 3,126 in the same period of 2024.
  • Germany’s health ministry, following an RKI recommendation, is keeping the National Reference Center for Borrelia at the LGL in Oberschleißheim with funding secured for the next three years.
  • Health officials note Lyme-Borreliose is the most common tick-borne disease in Germany and is generally treatable with antibiotics when diagnosed early.
  • Authorities advise prompt tick removal and monitoring for the characteristic ring-shaped rash, with the RKI noting that transmission typically requires several hours of attachment.
  • A Lyme vaccine candidate (VLA15 from Valneva and Pfizer) remains in testing, with regulatory filings planned for 2026 according to media reports.